Table 1 Characteristics of the individuals included in the study
From: LINGO1 rs9652490 and rs11856808 polymorphisms are not associated with risk for multiple sclerosis
Overall MS patients | RRMS | SPMS | PPMS | Control individuals | |
|---|---|---|---|---|---|
Gender (females/males) | 203/90 | 115/44 | 59/32 | 29/14 | 221/97 |
Age (mean ± SD) | 43.9 ± 11.4 | 40.0 ± 10.5 | 47.2 ± 9.9 | 54.4 ± 10.2 | 43.7 ± 12.4 |
Age at onset (mean ± SD) | 32.8 ± 10.9 | 29.5 ± 8.5 | 34.9 ± 11.8 | 43.4 ± 11.6 | -- |
Disease duration (mean ± SD) | 11.1 ± 7.9 | 10.5 ± 8.2 | 12.3 ± 9.3 | 11.0 ± 7.7 | -- |
Expanded disability status scale | 4.7 ± 2.2 | 2.9 ± 1.5 | 6.0 ± 1.3 | 6.8 ± 0.9 | -- |
Progression index (EDSS/MS duration) | 0.5 ± 0.4 | 0.3 ± 0.2 | 0.6 ± 0.5 | 0.7 ± 0.4 | -- |